ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

84.91 -4.15% (-3.68)

Over 1M: +0.3%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

86 88
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '21 — Revenue: 38.3M Q4 '21 — Operating Cash Flow: -24M Q4 '21 — Net Income: -63.4M Q1 '22 — Revenue: 27.4M Q1 '22 — Operating Cash Flow: -61.3M Q1 '22 — Net Income: -62.9M Q2 '22 — Revenue: 151.8M Q2 '22 — Operating Cash Flow: 62.7M Q2 '22 — Net Income: 44.4M Q3 '22 — Revenue: 32.4M Q3 '22 — Operating Cash Flow: -68.8M Q3 '22 — Net Income: -72M Q4 '22 — Revenue: 31.6M Q4 '22 — Operating Cash Flow: -68.7M Q4 '22 — Net Income: -85.5M Q1 '23 — Revenue: 62.5M Q1 '23 — Operating Cash Flow: -75.5M Q1 '23 — Net Income: -41.3M Q2 '23 — Revenue: 146.3M Q2 '23 — Operating Cash Flow: -31.7M Q2 '23 — Net Income: 48.7M Q3 '23 — Revenue: 15.8M Q3 '23 — Operating Cash Flow: -20.8M Q3 '23 — Net Income: -102.9M Q4 '23 — Revenue: 16.1M Q4 '23 — Operating Cash Flow: -25.9M Q4 '23 — Net Income: -109.7M Q1 '24 — Revenue: 3.6M Q1 '24 — Operating Cash Flow: -117.8M Q1 '24 — Net Income: -132.9M Q2 '24 — Revenue: 0 Q2 '24 — Operating Cash Flow: -92.4M Q2 '24 — Net Income: -125.3M Q3 '24 — Revenue: 0 Q3 '24 — Operating Cash Flow: -115.4M Q3 '24 — Net Income: -170.8M Q4 '24 — Revenue: 0 Q4 '24 — Operating Cash Flow: -137.2M Q4 '24 — Net Income: -170.5M Q1 '25 — Revenue: 2.5M Q1 '25 — Operating Cash Flow: -146.3M Q1 '25 — Net Income: -173.1M Q2 '25 — Revenue: 542.7M Q2 '25 — Operating Cash Flow: 460.1M Q2 '25 — Net Income: 370.4M Q3 '25 — Revenue: 27.8M Q3 '25 — Operating Cash Flow: -154.7M Q3 '25 — Net Income: -175.2M Q4 '25 — Revenue: 256.5M Q4 '25 — Operating Cash Flow: 20.5M Q4 '25 — Net Income: -23.8M Q1 '26 — Revenue: 264M Q1 '26 — Operating Cash Flow: 13.5M Q1 '26 — Net Income: 30.8M Q2 '26 — Revenue: 73.7M Q2 '26 — Operating Cash Flow: 84.4M Q2 '26 — Net Income: -132.7M Q3 '26 — Revenue: 75.3M Q3 '26 — Operating Cash Flow: -177.5M Q3 '26 — Net Income: -194.3M -150M 0 150M 300M 450M 600M
Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26
Revenue Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.1
SBC / sales 10.5%
OE margin -21.7%
Oper. margin -33.8%
Accruals -12.4%
EBITDA margin -30.2%
FCF margin -11.2%
OCF margin -8.8%
Profit margin -47.8%
ROA -15.1%
ROCE -12.4%
ROE -68.7%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.2
RPO / sales 0.14×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Cash / Debt 2.3×
Cash runway 12.2 yr
Debt payback 0.0 yr
Quick ratio 5.9×
F-score 5.1 pts
Debt / Eq 1.5×
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.3
Sales CAGR 4Y +56.5%
Sales/sh Y/Y +4.6%
Sales Q/Q +171.0%
Shares change +11.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.